The National Institute For Biotechnology in the Negev Ltd.
发明人:
Aharoni, Amir,Levin, Itay
申请号：
AU2015254818
公开号：
AU2015254818A1
申请日:
2015.04.27
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.
